Bell Investment Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.84K Sell
36
-2
-5% -$242 ﹤0.01% 1090
2026
Q1
$6.21K Sell
38
-36
-49% -$5.54K ﹤0.01% 878
2025
Q4
$12.9K Buy
74
+39
+111% +$7.12K ﹤0.01% 599
2025
Q3
$5.04K Buy
35
+8
+30% +$980 ﹤0.01% 933
2025
Q2
$2.72K Hold
27
– – ﹤0.01% 1235
2025
Q1
$2.06K Hold
27
– – ﹤0.01% 1299
2024
Q4
$1.86K Hold
27
– – ﹤0.01% 1358
2024
Q3
$1.97K Buy
27
+7
+35% +$517 ﹤0.01% 1362
2024
Q2
$1.34K Hold
20
– – ﹤0.01% 1516
2024
Q1
$543 Hold
20
– – ﹤0.01% 1797
2023
Q4
$620 Buy
+20
New +$519 ﹤0.01% 1750
2022
Q3
– Sell
-18
Closed – – 1824
2022
Q2
$0 Buy
+18
New +$377 ﹤0.01% 1776
2021
Q4
$1K Sell
39
-6
-13% -$172 ﹤0.01% 1474
2021
Q3
$1K Buy
+45
New +$1.18K ﹤0.01% 1417

Other funds holding INSM

Bell Investment Advisors's INSM Position: Q2 2026 in Review

Bell Investment Advisors reduced its Insmed (INSM) stake by 5.3% in Q2 2026, selling an estimated $242 and leaving 36 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Bell Investment Advisors first reported a position in INSM in Q3 2021 and has held it in 14 quarters since. The position peaked at $12.9K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bell Investment Advisors held 36 shares of Insmed worth $3.84K as of Q2 2026.
  • Bell Investment Advisors sold 2 Insmed shares in Q2 2026, an estimated $242.
  • Insmed made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1090 holding.
  • Bell Investment Advisors first reported a position in Insmed in Q3 2021 and has held it in 14 quarters since.
  • Bell Investment Advisors's Insmed position peaked at $12.9K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.